MedTrace Logo

Prevalence of Latent Tuberculosis in High Risk Children

NCT03910946 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-06-16

No results posted yet for this study

Summary

identify the prevalence of latent tuberculosis (according to new guideline ;NICE tuberculosis) among these high risk groups of children and notify ministry of health

Conditions

  • Latent Tuberculosis

Interventions

DRUG

Tuberculin, Purified Protein 5Unt/0.1 mL Solution

Tuberculosis (diagnosis)-Tuberculin, purified protein derivative (PPD) is indicated as a diagnostic aid in the detection of Mycobacterium tuberculosis infection. It is also indicated when BCG vaccination or isoniazid prophylaxis is being considered

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • nagla h. fargaly, professor · Assiut University

Eligibility

Min Age
1 Year
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2021-01-31
Completion
2021-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03910946 on ClinicalTrials.gov